Chanan-Khan A - Search Results

1

Bcl-2 antisense therapy in hematologic malignancies.

Chanan-Khan A. Chanan-Khan A. Curr Opin Oncol. 2004 Nov;16(6):581-5. doi: 10.1097/01.cco.0000142074.67968.eb. Curr Opin Oncol. 2004. PMID: 15627020 Review.

2

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics.

Sher T, Miller KC, Lawrence D, Whitworth A, Hernandez-Ilizaliturri F, Czuczman MS, Miller A, Lawrence W, Bilgrami SA, Sood R, Wood MT, Block AW, Lee K, Chanan-Khan AA. Sher T, et al. Leuk Lymphoma. 2010 Jan;51(1):85-8. doi: 10.3109/10428190903406806. Leuk Lymphoma. 2010. PMID: 20055660 Clinical Trial.

3

Bortezomib in combination with pegylated liposomal doxorubicin for the treatment of multiple myeloma.

Manochakian R, Miller KC, Chanan-Khan AA. Manochakian R, et al. Clin Lymphoma Myeloma. 2007 Jan;7(4):266-71. doi: 10.3816/CLM.2007.n.001. Clin Lymphoma Myeloma. 2007. PMID: 17324333 Review.

4

Pegylated liposomal doxorubicin and immunomodulatory drug combinations in multiple myeloma: rationale and clinical experience.

Chanan-Khan AA, Lee K. Chanan-Khan AA, et al. Clin Lymphoma Myeloma. 2007 Apr;7 Suppl 4:S163-9. doi: 10.3816/clm.2007.s.018. Clin Lymphoma Myeloma. 2007. PMID: 17562255 Review.

5

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.

Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM. Chanan-Khan A, et al. Ann Oncol. 2003 Sep;14(9):1430-7. doi: 10.1093/annonc/mdg374. Ann Oncol. 2003. PMID: 12954584

6

Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.

Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthy PL Jr, Alam AR. Ahmad I, et al. Bone Marrow Transplant. 2002 Apr;29(7):577-80. doi: 10.1038/sj.bmt.1703522. Bone Marrow Transplant. 2002. PMID: 11979306

7

Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.

Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH. Czuczman MS, et al. J Clin Oncol. 2005 Feb 1;23(4):694-704. doi: 10.1200/JCO.2005.02.172. J Clin Oncol. 2005. PMID: 15681517 Clinical Trial.

8

Non-Hodgkin's lymphoma presenting as a breast mass in patients with HIV infection: a report of three cases.

Chanan-Khan A, Holkova B, Goldenberg AS, Pavlick A, Demopoulos R, Takeshita K. Chanan-Khan A, et al. Leuk Lymphoma. 2005 Aug;46(8):1189-93. doi: 10.1080/10428190500084175. Leuk Lymphoma. 2005. PMID: 16085561

9

The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide.

O'Connor OA, Smith EA, Toner LE, Teruya-Feldstein J, Frankel S, Rolfe M, Wei X, Liu S, Marcucci G, Chan KK, Chanan-Khan A. O'Connor OA, et al. Clin Cancer Res. 2006 May 1;12(9):2902-11. doi: 10.1158/1078-0432.CCR-05-0308. Clin Cancer Res. 2006. PMID: 16675587

10

Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.

Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG. Chanan-Khan A, et al. J Clin Oncol. 2008 Oct 10;26(29):4784-90. doi: 10.1200/JCO.2007.14.9641. Epub 2008 Aug 18. J Clin Oncol. 2008. PMID: 18711175 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results